Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.
about
Investigations into viomycin biosynthesis by using heterologous production in Streptomyces lividansTrisubstituted Imidazoles as Mycobacterium tuberculosis Glutamine Synthetase InhibitorsRisk factors for MDR and XDR-TB in a tertiary referral hospital in IndiaTreatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysisDrug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South AfricaHigh frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosisDrug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.Isolation of anti-mycobacterial compounds from Curtisia dentata (Burm.f.) C.A.Sm (Curtisiaceae).Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.Mechanistically distinct nonribosomal peptide synthetases assemble the structurally related antibiotics viomycin and capreomycin.Analysis of undiagnosed tuberculosis-related deaths identified at post-mortem among HIV-infected patients in Russia: a descriptive studyMicrowave-assisted synthesis of small molecules targeting the infectious diseases tuberculosis, HIV/AIDS, malaria and hepatitis C.Illness perception in tuberculosis by implementation of the Brief Illness Perception Questionnaire - a TBNET study.Molecular characterization of fluoroquinolone resistance in Mycobacterium tuberculosis: functional analysis of gyrA mutation at position 74.Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosisResistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomesPrimary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.Microevolution of extensively drug-resistant tuberculosis in Russia.Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis.Acquired resistance to second-line drugs among persons with tuberculosis in the United States.Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.Extensively drug-resistant tuberculosis: new strains, new challenges.TBNET - Collaborative research on tuberculosis in Europe.Update in tuberculosis 2008.Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy.De-novo XDR Tuberculosis Spine in a 3-year-old Girl.The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: part I: the origins and nature of the problem.Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, ChinaMultidrug- and extensively drug-resistant TB in persons living with HIV.Factors associated with multidrug-resistant tuberculosis: comparison of patients born inside and outside of the Czech Republic.Molecular Quantum Similarity, Chemical Reactivity and Database Screening of 3D Pharmacophores of the Protein Kinases A, B and G from Mycobacterium tuberculosis.Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.Validity of Time to Sputum Culture Conversion to Predict Cure in Patients with Multidrug-Resistant Tuberculosis: A Retrospective Single-Center Study.Of Blind Men and Elephants: Making Sense of Extensively Drug-resistant TuberculosisUpdate on clinical research of tuberculosis: a report from the European Respiratory Society
P2860
Q24649829-B6AD96A0-F900-46B7-9F83-A0219D1EC235Q27677505-35C293C3-2A28-40A7-A1D6-8A17F1D56F8AQ28473088-41615C55-2FEF-4279-AB4E-781FEBB61417Q28476110-8E717667-5968-44FA-9DE0-0193EA2BBE41Q28487731-900300E3-24CE-4659-90D4-87B12FB7AA14Q28546682-6F28C2C4-CA43-4D3C-9AC3-ABA761770E19Q30573127-FA98BEAA-6B68-4C40-948C-04B3CAB99A5CQ33503956-1C6CF051-1DB1-4C6A-8AE7-A2B2FEB6CAFEQ33791853-4A078DF5-013D-4481-8528-CF2A5DEC37E8Q33794794-A305E343-52FC-4C65-83A9-B48C8F160EF6Q33955617-4641BB80-CCFB-4A9C-A5B4-36E56560F608Q34050898-A2351D09-5BBA-4DF8-96D3-F74143124823Q34121361-71843C23-6824-4A41-8A45-8A82273EFA20Q34517280-B93F3140-446A-4788-B95C-DBB6DF896A26Q34529276-65AD8114-19BF-42D5-A638-1CE4DD27C590Q34643194-FCE6033E-B061-42F8-B8FF-9E6565710E6AQ35805940-CC36123B-9413-447F-8837-ED685C98ABD7Q35850402-A7A81DE9-C4B8-4B57-9F6A-5D54C2CC451AQ35864738-E421D5A3-289F-4B2D-BFA1-06F3CBE6F6B0Q36364095-1AAEC376-8102-4EE4-A61B-D3F9523DD0A9Q36593003-D6963E8D-BC8A-435F-8C6E-BAC3C63C5C9AQ36892368-385F8967-251B-4BE4-B7F4-4591A8E0EA95Q37291363-2A0FBE55-2B6A-4C8E-8199-B9036413FEA3Q37319949-833053F4-B2D7-4881-9C3A-B11E3B9C85B1Q37398528-72A86462-BA16-42CB-836F-3AC15EBEB861Q37669577-8D3A7063-2C99-4CA5-8294-F4C694E61574Q37695807-44917D88-AF45-4D37-A80F-0D817AD7D1C3Q37700331-E0CDB035-BAE7-4DBC-B979-2080EA021248Q38040155-612E41AE-9DBF-41D2-AC02-7C1F5C164987Q38231137-781F1158-956F-4300-8BD3-A11385FC3F09Q38644773-71D48510-ACBD-46B2-AED3-9C16B2EF2BADQ39226104-290056D4-0D1F-4205-B104-368BF4228726Q42916605-C0F9ED1D-ADF0-4D83-BBE1-BE7ABA458490Q50932369-86F88ACA-01F7-46EF-8C30-ACC759186A95Q53477294-1DC1DB1E-1FE8-443A-9481-35C0DF4EF73BQ53699025-52007D31-85D8-492C-B630-991B944BFFC6Q56838308-CBA0DA5D-CB50-462D-97EE-F51E29154D75Q56838311-F17F80AA-657D-408F-9849-5F7F993708CC
P2860
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Resistance to second-line inje ...... -resistant tuberculosis cases.
@en
Resistance to second-line inje ...... -resistant tuberculosis cases.
@nl
type
label
Resistance to second-line inje ...... -resistant tuberculosis cases.
@en
Resistance to second-line inje ...... -resistant tuberculosis cases.
@nl
prefLabel
Resistance to second-line inje ...... -resistant tuberculosis cases.
@en
Resistance to second-line inje ...... -resistant tuberculosis cases.
@nl
P2093
P50
P1476
Resistance to second-line inje ...... g-resistant tuberculosis cases
@en
P2093
D M Cirillo
F N Lauria
H Hoffmann
M D Richardson
R Mütterlein
TBNET Study Group
P304
P356
10.1183/09031936.00028708
P577
2008-06-01T00:00:00Z